Skip to content

APOTHEEK NOTEBAERT

Active
Public limited company·Detailhandel in farmaceutische producten· 29 yrs active
Markt 20 ·8730 Beernem, Belgium
KBO/BCE: BE 0461.051.985
Watch Print / PDF
Age29 yrs

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of APOTHEEK NOTEBAERT is 0.6% (low). The 2025 annual accounts show negative equity (€-52k) and a net result of €-37k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 16% of 480 sector peers (fiscal year 2025). The company has been active since 1997 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 8 annual accounts.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.6% Low
0%0,5%1,5%4%10%≥25%
Long track record Higher-failure-rate sector +Lower-risk legal form

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Signals

1 signal · with evidence
Negative equity
Equity is negative for financial year 2025: liabilities exceed assets. This is the trigger point of the alarm-bell procedure (Belgian CAC).
View the annual accounts

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide
Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 11-06-2026, 50 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.
The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
How we compute the deadline
The year end is derived from 10 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2025, that is 31-07-2026.
Deadline per financial year
Year closed Due by Filed Variance Reference
31-12-2025 31-07-2026 11-06-2026 50 d early 2026-00152288
31-12-2024 31-07-2025 30-06-2025 31 d early 2025-00194576
31-12-2023 31-07-2024 13-06-2024 48 d early 2024-00125814
31-12-2022 31-07-2023 30-08-2023 30 d late 2023-00375073
31-12-2021 31-07-2022 15-07-2022 16 d early 2022-20188872
31-12-2020 31-07-2021 28-05-2021 64 d early 2021-15800068
31-12-2019 31-07-2020 23-07-2020 8 d early 2020-33100146
31-12-2018 31-07-2019 15-07-2019 16 d early 2019-32200470
31-12-2017 31-07-2018 16-07-2018 15 d early 2018-32700112
31-12-2016 31-07-2017 25-07-2017 6 d early 2017-34700094

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals
Long-established
Founded in 1997, 29 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€-37k-17.0%
Working capital€198k-8.6%

Annual accounts & ratios

Source: NBB · 2025
Annual accounts filed on 11-06-2026 with the NBB · fiscal year 2025 · verkort
€-150k€-100k€-50k€0Operating result 2021: €-120k€-120kNet result 2021: €-130k€-130kOperating result 2022: €-19k€-19kNet result 2022: €-42k€-42kOperating result 2023: €-13k€-13kNet result 2023: €-45k€-45kOperating result 2024: €-5k€-5kNet result 2024: €-32k€-32kOperating result 2025: €-13k€-13kNet result 2025: €-37k€-37k20212022202320242025
Operating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
volatile Too volatile to project: the yearly deviation from the trend is ~38% of the level (threshold 35%). We therefore deliberately show no projection line.
€-100k€0€100k€200k2018: €87k2019: €117k2020: €174k2021: €45k2022: €2k2023: €-42k2024: €-14k2025: €-52k20182019202020212022202320242025
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2025 · NACE 47, Retail trade · compared within the same schema type (abbreviated schema)
Metric This company Sector median Position in the sector
Solvency -2.6% 21.2%
better than 16% of 480 sector peers
Net result €-37k €32k
better than 17% of 478 sector peers
Equity €-52k €163k
better than 12% of 480 sector peers
Gross operating margin €422k €281k
better than 66% of 480 sector peers
Staff costs €350k €211k
higher than 67% of 386 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Sector position over time
Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).
Solvency P16
2020: P45 · n=5532021: P19 · n=6912022: P19 · n=9192023: P18 · n=10832024: P19 · n=12302025: P16 · n=4802020 2025
Stable position over 2020-2025 · n=480-1230
Net result P17
2020: P67 · n=5532021: P5 · n=6892022: P15 · n=9202023: P14 · n=10822024: P16 · n=12292025: P17 · n=4782020 2025
Stable position over 2020-2025 · n=478-1229
Equity P12
2020: P45 · n=5532021: P27 · n=6912022: P20 · n=9202023: P12 · n=10842024: P15 · n=12302025: P12 · n=4802020 2025
Weakening position over 2020-2025 · n=480-1230
Gross operating margin P66
2020: P72 · n=5532021: P62 · n=6892022: P67 · n=9182023: P73 · n=10822024: P71 · n=12282025: P66 · n=4802020 2025
Stable position over 2020-2025 · n=480-1228
Describes the position versus peers, not a forecast.
EBITDA
€67k
-9.9% 18-25
Net profit
€-37k
-17.0% 18-25
Cash flow
€42k
-11.3% 18-25
Total assets
€1.98M
-1.9% 18-25
Equity
€-52k
-260.9% 18-25
Working capital
€198k
-8.6% 18-25
Employees (FTE)
5
0.0% 18-25
Staff costs
€350k
+3.8% 18-25
Show 11 other metrics
Income taxes
€0
- 18-25
Debt
€2.03M
0.0% 18-25
Debt ≤ 1y
€246k
+24.8% 18-25
Debt > 1y
€1.78M
-2.7% 18-25
Current ratio
1.80
-14.0% 18-25
Quick ratio
0.83
-11.4% 18-25
Solvency
-2.6%
-267.8% 18-25
Debt / equity
-39.36
+72.3% 18-25
ROE
72.3%
-67.6% 18-25
ROA
-1.9%
-19.2% 18-25
Interest coverage
2.41
-7.8% 18-25
Figures by fiscal year
Fiscal year2025
Depositverkort
Revenue-
EBITDA€67k
Net profit€-37k
Cash flow€42k
Staff costs€350k
Income taxes-
Dividends-
Total assets€1.98M
Equity€-52k
Debt€2.03M
of which ≤ 1y€246k
of which > 1y€1.78M
Working capital€198k
Employees (FTE)4.6
Ratios (computed)
2025
Current ratio1.80
Quick ratio0.83
Working capital ratio10.0%
Solvency-2.6%
Debt / equity-39.36
Long-term debt ratio-34.58
Interest coverage2.41
Gross margin-
Net margin-
ROA-1.9%
ROE72.3%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2025
Full annual accounts (23 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2025
Balance sheet, Assets
TOTAL ASSETS 20/58€1.98M
Fixed assets 21/28€1.53M
Tangible fixed assets 22/27€1.53M
Current assets 29/58€444k
Stocks & contracts in progress 3€241k
Amounts receivable within one year 40/41€118k
Cash & bank 54/58€76k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€1.98M
Equity 10/15€-52k
Contributions / capital 10/11€122k
Reserves 13€6k
Accumulated profits (losses) 14€-180k
Amounts payable 17/49€2.03M
Amounts payable after one year 17€1.78M
Amounts payable within one year 42/48€246k
Trade debts payable within one year 44€105k
Income statement
Gross operating margin 9900€422k
Operating result 9901€-13k
Financial income 75€3k
Financial charges 65€28k
Result before taxes 9903€-37k
Net result for the period 9904€-37k
Result to be appropriated 9905€-37k
This table shows the latest fiscal year. 4 prior years, with figures and ratios, belong to a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2025 · computed
45 / 100 Fair
050100
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.

See plans →
Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.

Structure & network

Locations & real estate

Registered office

on the map · from the address register
exact location from the address register On OpenStreetMap

Establishment units

1 location
APOTHEEK NOTEBAERT
Markt 20, 8730 BeernemOverige detailhandel in voedings- en genotmiddelen in gespecialiseerde winkels
since 19972.083.353.726
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area252 m²
Buildings1
Building footprint222 m²
Volume (LiDAR)1,213 m³
Tallest building12.4 m · ±2 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
31021B0044/00V000 Flanders 252 m² 1 · 222 m² 12.4 m · 2 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgisch Staatsblad · acts

1 act
Capital history · 1
29-05-2024
Capital change
All acts · 1 updated 2 years ago
2024
29-05-2024 Capital increase of €60,000 to €121,973.38 Capital & shares·Axelle THIERY
  • €61.973,38 → €121.973,38
  • Inbreng in geld · Apport en numéraire
Notary: Axelle THIERY · Roeselare

Analysis

Financial profile

5 of 5 axes measured
Health45Profitability100Solvency62Growth32Stability100
68 / 100

Strong profile, led by profitability.

All 5 axes are computed from data Checked has read.

Health 45
Profitability 100
Solvency 62
Growth 32
Stability 100

Credit advice

verdict per customer and amount

May this customer buy amount X on invoice? Enter the amount and the payment term. This page computes a GREEN, AMBER or RED verdict from them, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Comparable size, same sector

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Detailhandel in farmaceutische producten47730Apothekers52310
Primary activity highlighted.
Names & trade names
Legal nameNL APOTHEEK NOTEBAERT
Registered office
Markt 20
8730 Beernem, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.